NAD Supplementation and Vascular Health in PAD
NCT06534944
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Peripheral Artery Disease
Interventions
DRUG:
Nicotinamide riboside
Sponsor
University of Oklahoma